Medical Bulletin 3/November/2021

Here are Top Medical Stories of the day

Bedtime Snacks Tied To Moderate Increase In Fasting Blood Sugar In Gestational Diabetes: Study

A recent study in the journal Diabetic Medicine has found that taking a bedtime snack slightly increases fasting blood sugar levels in women with diet-controlled gestational diabetes versus taking no bedtime snack.

In the study, Dorothy F. Graham, University of Western Australia, Nedlands, Western Australia, Australia, and colleagues set out to determine the effect of different bedtime snacks (higher carbohydrate versus lower carbohydrate versus no snack) on the first morning fasting blood glucose levels (BGLs) in women with diet-controlled gestational diabetes mellitus (GDM) and borderline fasting glucose levels.

For more details, check out the full story on the link below:

Bedtime Snacks Tied To Moderate Increase In Fasting Blood Sugar In Gestational Diabetes: Study

Nebulized Revefenacin Improves Health Status Of Patients With Moderate To Very Severe COPD-a study reports

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and disability, investigation is essential for better management in both men and women.

A randomized trial by Gary Ferguson and team revealed that nebulized revefenacin produced significant improvements in COPD Assessment Test (CAT) scores in women and men with moderate to very severe COPD, they also revealed significant improvements in St George's Respiratory Questionnaire (SGRQ) scores in women alone when compared with placebo. Maintenance treatment with revefenacin can improve health status of patients with moderate to very severe COPD; however, the effect may be more pronounced in women than men.

For more details, check out the full story on the link below:

Nebulized Revefenacin Improves Health Status Of Patients With Moderate To Very Severe COPD: Study

Chest CT Score Predicts Response Of COVID-19 Pneumonia Patients 

A recent study published in the Journal of Cardiothoracic and Vascular Anesthesia, has reported the effective use of non-invasive positive pressure ventilation (NPPV) in COVID-19 pneumonia patients. Luca Arcari, Covid-Cardiology Unit, Madre Giuseppina Vannini Hospital, Rome, Italy, and colleagues found that a semi-quantitative chest CT analysis at hospital admission may accurately identify people who respond poorly to NPPV.

Coronavirus disease-19 (COVID-19) is a respiratory tract infection having a significant rate of respiratory insufficiency, mortality, hospitalization need. NPPV is an emerging efficient tool for the treatment of Coronavirus disease-19 (COVID-19) pneumonia. However, the factors that influence the failure of NPPV are still elusive. Arcari and the team aimed to investigate the relationships between semiquantitative chest computed tomography (CT) scoring and NPPV failure and mortality in patients with COVID-19 in an observational study.

For more details, check out the full story on the link below:

Chest CT Score Predicts Response Of COVID-19 Pneumonia Patients To Ventilation: Study

Oral Contraceptives Tied To Lower Risk Of Dysglycemia In Women With PCOS

The use of combined oral contraceptive pills (COCP) in women with polycystic ovary syndrome (PCOS) reduces the risk of dysglycemia regardless of their body mass index, a recent study has suggested. The findings, published in the journal Diabetes Care, support "the recommendation that women with PCOS should be screened for type 2 diabetes irrespective of bodyweight category.

Irregular menstrual cycles are related to increased cardiovascular mortality. PCOS is a hormonal disorder characterized by irregular menses and androgen excess. Androgens are known to increase metabolic risk in PCOS women. COCPs are used in PCOS both to reduce the biologically active androgen fraction and for cycle regulation.

For more details, check out the full story on the link below:

Oral Contraceptives Tied To Lower Risk Of Dysglycemia In Women With PCOS: Study

'Nanozyme' Therapy Significantly Reduced Buildup Of Harmful Dental Plaque: Study

A growing body of evidence points to a link between iron-deficiency anemia and severe tooth decay. Whether the connection is correlative or causative is unknown, though both conditions are associated with poor diets and are more common in people living in impoverished environments and with underlying medical conditions.

Researchers from the University of Pennsylvania and Indiana University have found that a combination of an iron-oxide nanoparticle-containing solution called ferumoxytol and hydrogen peroxide holds promise for treating, preventing, and even diagnosing dental decay. The combination is an FDA-approved therapy for iron-deficiency anemia.

For more details, check out the full story on the link below:

'Nanozyme' Therapy Significantly Reduced Buildup Of Harmful Dental Plaque: Study